![PDF) Corrigendum: Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management PDF) Corrigendum: Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management](https://i1.rgstatic.net/publication/320766248_Corrigendum_Third_European_Evidence-based_Consensus_on_Diagnosis_and_Management_of_Ulcerative_Colitis_Part_2_Current_Management/links/5a019efda6fdcc232e2c7b4d/largepreview.png)
PDF) Corrigendum: Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management
![Frontiers | Combination Immunotherapy Use and Withdrawal in Pediatric Inflammatory Bowel Disease—A Review of the Evidence Frontiers | Combination Immunotherapy Use and Withdrawal in Pediatric Inflammatory Bowel Disease—A Review of the Evidence](https://www.frontiersin.org/files/Articles/708310/fped-09-708310-HTML/image_m/fped-09-708310-g001.jpg)
Frontiers | Combination Immunotherapy Use and Withdrawal in Pediatric Inflammatory Bowel Disease—A Review of the Evidence
![Journal of Prescribing Practice - Nurse-led early evaluation following corticosteroid prescription in patients with inflammatory bowel disease Journal of Prescribing Practice - Nurse-led early evaluation following corticosteroid prescription in patients with inflammatory bowel disease](https://www.prescribingpractice.com/media/tncdlblx/jprp-2021-3-12-500_f01.jpg)
Journal of Prescribing Practice - Nurse-led early evaluation following corticosteroid prescription in patients with inflammatory bowel disease
![Cureus | Prediction of Mucosal Health by NLR, CRP x NLR and MPV in Ulcerative Colitis: Can Their Availability Change According to Treatment Options? | Article Cureus | Prediction of Mucosal Health by NLR, CRP x NLR and MPV in Ulcerative Colitis: Can Their Availability Change According to Treatment Options? | Article](https://assets.cureus.com/uploads/figure/file/286749/article_river_b8b7ea60463311ecb976955336d4f7bc-Figure-1.png)
Cureus | Prediction of Mucosal Health by NLR, CRP x NLR and MPV in Ulcerative Colitis: Can Their Availability Change According to Treatment Options? | Article
![Frontiers | The IL23-IL17 Immune Axis in the Treatment of Ulcerative Colitis: Successes, Defeats, and Ongoing Challenges Frontiers | The IL23-IL17 Immune Axis in the Treatment of Ulcerative Colitis: Successes, Defeats, and Ongoing Challenges](https://www.frontiersin.org/files/Articles/611256/fimmu-12-611256-HTML/image_m/fimmu-12-611256-g001.jpg)
Frontiers | The IL23-IL17 Immune Axis in the Treatment of Ulcerative Colitis: Successes, Defeats, and Ongoing Challenges
![Genetic and dietary modulators of the inflammatory response in the gastro-intestinal tract of the BXD mouse genetic reference population Genetic and dietary modulators of the inflammatory response in the gastro-intestinal tract of the BXD mouse genetic reference population](https://prod--epp.elifesciences.org/iiif/2/87569%2Fv2%2F533818v2_fig4.tif/full/max/0/default.jpg)
Genetic and dietary modulators of the inflammatory response in the gastro-intestinal tract of the BXD mouse genetic reference population
![Genetic and dietary modulators of the inflammatory response in the gastro-intestinal tract of the BXD mouse genetic reference population Genetic and dietary modulators of the inflammatory response in the gastro-intestinal tract of the BXD mouse genetic reference population](https://prod--epp.elifesciences.org/iiif/2/87569%2Fv2%2F533818v2_tbls1.tif/full/max/0/default.jpg)
Genetic and dietary modulators of the inflammatory response in the gastro-intestinal tract of the BXD mouse genetic reference population
![Journal of Prescribing Practice - Nurse-led early evaluation following corticosteroid prescription in patients with inflammatory bowel disease Journal of Prescribing Practice - Nurse-led early evaluation following corticosteroid prescription in patients with inflammatory bowel disease](https://www.prescribingpractice.com/media/ragnmtv4/adobestock_242330515.jpeg)
Journal of Prescribing Practice - Nurse-led early evaluation following corticosteroid prescription in patients with inflammatory bowel disease
![PDF) Predictors and Early Markers of Response to Biological Therapies in Inflammatory Bowel Diseases PDF) Predictors and Early Markers of Response to Biological Therapies in Inflammatory Bowel Diseases](https://i1.rgstatic.net/publication/349452862_Predictors_and_Early_Markers_of_Response_to_Biological_Therapies_in_Inflammatory_Bowel_Diseases/links/60308f05a6fdcc37a83ac45a/largepreview.png)
PDF) Predictors and Early Markers of Response to Biological Therapies in Inflammatory Bowel Diseases
![Frontiers | Investigating dysbiosis and microbial treatment strategies in inflammatory bowel disease based on two modified Koch's postulates Frontiers | Investigating dysbiosis and microbial treatment strategies in inflammatory bowel disease based on two modified Koch's postulates](https://www.frontiersin.org/files/Articles/1023896/fmed-09-1023896-HTML/image_m/fmed-09-1023896-g001.jpg)
Frontiers | Investigating dysbiosis and microbial treatment strategies in inflammatory bowel disease based on two modified Koch's postulates
![Frontiers | Dehydrocostus Lactone Suppresses Dextran Sulfate Sodium-Induced Colitis by Targeting the IKKα/β-NF-κB and Keap1-Nrf2 Signalling Pathways Frontiers | Dehydrocostus Lactone Suppresses Dextran Sulfate Sodium-Induced Colitis by Targeting the IKKα/β-NF-κB and Keap1-Nrf2 Signalling Pathways](https://www.frontiersin.org/files/Articles/817596/fphar-13-817596-HTML/image_m/fphar-13-817596-g006.jpg)
Frontiers | Dehydrocostus Lactone Suppresses Dextran Sulfate Sodium-Induced Colitis by Targeting the IKKα/β-NF-κB and Keap1-Nrf2 Signalling Pathways
![Frontiers | Role of Eosinophils in Intestinal Inflammation and Fibrosis in Inflammatory Bowel Disease: An Overlooked Villain? Frontiers | Role of Eosinophils in Intestinal Inflammation and Fibrosis in Inflammatory Bowel Disease: An Overlooked Villain?](https://www.frontiersin.org/files/MyHome%20Article%20Library/754413/754413_Thumb_400.jpg)
Frontiers | Role of Eosinophils in Intestinal Inflammation and Fibrosis in Inflammatory Bowel Disease: An Overlooked Villain?
![Living with Ulcerative Colitis Study (LUCY) in England: a retrospective study evaluating healthcare resource utilisation and direct healthcare costs of postoperative care in ulcerative colitis | BMJ Open Gastroenterology Living with Ulcerative Colitis Study (LUCY) in England: a retrospective study evaluating healthcare resource utilisation and direct healthcare costs of postoperative care in ulcerative colitis | BMJ Open Gastroenterology](https://bmjopengastro.bmj.com/content/bmjgast/7/1/e000456/F1.large.jpg)
Living with Ulcerative Colitis Study (LUCY) in England: a retrospective study evaluating healthcare resource utilisation and direct healthcare costs of postoperative care in ulcerative colitis | BMJ Open Gastroenterology
![The immunomodulatory effects of probiotics and azithromycin in dextran sodium sulfate-induced ulcerative colitis in rats via TLR4-NF-κB and p38-MAPK pathway - ScienceDirect The immunomodulatory effects of probiotics and azithromycin in dextran sodium sulfate-induced ulcerative colitis in rats via TLR4-NF-κB and p38-MAPK pathway - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0753332223007953-ga1.jpg)
The immunomodulatory effects of probiotics and azithromycin in dextran sodium sulfate-induced ulcerative colitis in rats via TLR4-NF-κB and p38-MAPK pathway - ScienceDirect
![Frontiers | The Communication Between Intestinal Microbiota and Ulcerative Colitis: An Exploration of Pathogenesis, Animal Models, and Potential Therapeutic Strategies Frontiers | The Communication Between Intestinal Microbiota and Ulcerative Colitis: An Exploration of Pathogenesis, Animal Models, and Potential Therapeutic Strategies](https://www.frontiersin.org/files/Articles/766126/fmed-08-766126-HTML-r1/image_m/fmed-08-766126-g001.jpg)
Frontiers | The Communication Between Intestinal Microbiota and Ulcerative Colitis: An Exploration of Pathogenesis, Animal Models, and Potential Therapeutic Strategies
Ulcerative colitis progression: a retrospective analysis of disease burden using electronic medical records
![Frontiers | Thiopurines in Inflammatory Bowel Disease. How to Optimize Thiopurines in the Biologic Era? Frontiers | Thiopurines in Inflammatory Bowel Disease. How to Optimize Thiopurines in the Biologic Era?](https://www.frontiersin.org/files/MyHome%20Article%20Library/681907/681907_Thumb_400.jpg)
Frontiers | Thiopurines in Inflammatory Bowel Disease. How to Optimize Thiopurines in the Biologic Era?
![Frontiers | Gastroenterologists Adherence to Tumor Necrosis Factor Antagonist Combination Therapy in Inflammatory Bowel Disease Frontiers | Gastroenterologists Adherence to Tumor Necrosis Factor Antagonist Combination Therapy in Inflammatory Bowel Disease](https://www.frontiersin.org/files/Articles/725512/fmed-08-725512-HTML/image_m/fmed-08-725512-g001.jpg)
Frontiers | Gastroenterologists Adherence to Tumor Necrosis Factor Antagonist Combination Therapy in Inflammatory Bowel Disease
![The current state of the art for biological therapies and new small molecules in inflammatory bowel disease - ScienceDirect The current state of the art for biological therapies and new small molecules in inflammatory bowel disease - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1933021922005979-gr1.jpg)
The current state of the art for biological therapies and new small molecules in inflammatory bowel disease - ScienceDirect
Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management | Journal of Crohn's and Colitis | Oxford Academic
![Constipation in ulcerative colitis: pathophysiology and practical management | Frontline Gastroenterology Constipation in ulcerative colitis: pathophysiology and practical management | Frontline Gastroenterology](https://fg.bmj.com/sites/default/files/highwire/flgastro/12/6.cover-source.jpg)
Constipation in ulcerative colitis: pathophysiology and practical management | Frontline Gastroenterology
![The long-term effect of biologics in patients with ulcerative colitis emerging from a large Japanese cohort | Scientific Reports The long-term effect of biologics in patients with ulcerative colitis emerging from a large Japanese cohort | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-022-25218-x/MediaObjects/41598_2022_25218_Fig1_HTML.png)